Ángel M. Martínez‐Montes

Author

Spanish National Cancer Research Centre ORCID

Also Known As

Angel M Martinez-Montes, Angel Martinez-Montes, Angel Martinez‐Montes, Martínez-Montes, Ángel M., Ángel M Martínez-Montes, Ángel M Martínez‐Montes, Ángel M. Martínez-Montes, Ángel M. Martínez‐Montes, Ángel Mario Martinez-Montes, Ángel Mario Martínez‐Montes

Publications

416

Citations

H-Index

Concepts

All Affiliations

Spanish National Cancer Research Centre Centre for Biomedical Network Research on Rare Diseases Hospital Universitario La Paz Centro de Investigación Biomédica en Red Hospital Universitario 12 De Octubre

ÁM

About

Ángel M. Martínez‐Montes is an author at Spanish National Cancer Research Centre specializing in medicine, pathology, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	87
2	Pathology	2	2	87
3	Cancer Cell Biology	1	1	39
4	Cancer Genetics	1	1	39
5	Epigenetic Regulation	1	1	39

Ángel M. Martínez‐Montes

Publications

366

Citations

H-Index

Page 1

	Year	Citations
Genomic and immune landscape Of metastatic pheochromocytoma and paraganglioma Bruna Calsina, Elena Piñeiro-Yáñez, Ángel M. Martínez‐Montes, Nature Communications	2023	86
Integrative multi-omics analysis identifies a prognostic miRNA signature and a targetable miR-21-3p/TSC2/mTOR axis in metastatic pheochromocytoma/paraganglioma Bruna Calsina, Luis Jaime Castro‐Vega, Rafael Torres‐Pérez, Theranostics	2019	65
Molecular characterization of chromophobe renal cell carcinoma reveals mTOR pathway alterations in patients with poor outcome Juan María Roldán‐Romero, María Santos, Javier Lanillos, Modern Pathology Molecular CharacterizationUrologyPathway AlterationsPoor OutcomeGenitourinary Cancer	2020	48
Succinate Mediates Tumorigenic Effects via Succinate Receptor 1: Potential for New Targeted Treatment Strategies in Succinate Dehydrogenase Deficient Paragangliomas Dieter M. Matlac, Katerina Hadrava Vanova, Nicole Bechmann, Frontiers in Endocrinology	2021	42
Hsa‐miR‐139‐5p is a prognostic thyroid cancer marker involved in HNRNPF‐mediated alternative splicing Cristina Montero‐Conde, Osvaldo Graña‐Castro, Guillermo Martín‐Serrano, International Journal of Cancer GeneticsPathologyCancer BiologySplicing VariantTumor Biology	2019	39
Analysis of Telomere Maintenance Related Genes Reveals NOP10 as a New Metastatic-Risk Marker in Pheochromocytoma/Paraganglioma María Monteagudo, Paula Martínez, Luis J. Leandro‐García, Cancers	2021	23
Comprehensive molecular analysis of immortalization hallmarks in thyroid cancer reveals new prognostic markers Cristina Montero‐Conde, Luis J. Leandro‐García, Ángel M. Martínez‐Montes, Clinical and Translational Medicine	2022	20
Deubiquitinase <scp>USP9X</scp> loss sensitizes renal cancer cells to <scp>mTOR</scp> inhibition Juan María Roldán‐Romero, Carlos Valdivia, María Santos, International Journal of Cancer	2023	18
Novel DNMT3A Germline Variant in a Patient with Multiple Paragangliomas and Papillary Thyroid Carcinoma Sara Mellid, Javier Pardo de Santayana y Coloma, Bruna Calsina, Cancers	2020	14
CD133 Expression in Medullary Thyroid Cancer Cells Identifies Patients with Poor Prognosis Alfonso Cordero‐Barreal, Eduardo Caleiras, Evangelina López de Maturana, The Journal of Clinical Endocrinology & Metabolism	2020	11

Page 1